Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.
Su Y, Zhang Y, Hua X, Huang J, Bi X, Xia W, Wang X, Huang Z, Song C, Zhong Y, Shi Y, Wang S; South China Breast Cancer Group (SCBCG); Fan W, Yuan Z. Su Y, et al. Among authors: song c. Ther Adv Med Oncol. 2021 Feb 26;13:1758835921993436. doi: 10.1177/1758835921993436. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33737962 Free PMC article.
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (SYSUCC-005).
Duan F, Zhong M, Ma Y, Song C, Zhang L, Lin Y, Wu Z, Zhang Y, Huang J, Xu F, Shi Y, Wang S, Yuan Z, Xia W, Bi X. Duan F, et al. Among authors: song c. BMC Cancer. 2022 Mar 15;22(1):271. doi: 10.1186/s12885-022-09399-2. BMC Cancer. 2022. PMID: 35291977 Free PMC article. Clinical Trial.
11,459 results
You have reached the last available page of results. Please see the User Guide for more information.